India Allergy Treatment Market Overview, 2030

India's market for allergy treatments is steadily growing, influenced by the increasing prevalence of allergic conditions and the significant impact of urban development. The rapid migration of people to urban areas has changed environmental factors, with elevated air pollution, industrial waste, construction dust, and vehicle emissions leading to a rise in respiratory allergies like asthma and allergic rhinitis. City living also heightens exposure to indoor allergens such as dust mites, mould spores, and pet hair especially in small, poorly ventilated homes. At the same time, changes in diet, less outdoor exercise, and differences in early microbial exposure are affecting immune systems, contributing to a rise in food allergies and atopic dermatitis. Growing public awareness, improved diagnostic tools, and a rising middle class with better access to healthcare are boosting the demand for prompt treatment and innovative therapies. The market continues to be supported by over-the-counter antihistamines, corticosteroid sprays, and topical treatments for mild to moderate symptoms, widely found in both retail and hospital pharmacies. Nonetheless, prescription treatments like leukotriene receptor antagonists, biologics for severe asthma and eczema, and specific allergen immunotherapy are becoming more popular in specialist clinics and advanced care facilities, especially in larger cities. The increase in smartphone use and the rise of telemedicine are helping online pharmacies reach areas that are semi-urban and rural, adding to traditional distribution methods. Government actions, such as enhancing air quality laws and boosting primary healthcare systems, are indirectly aiding allergy prevention and management strategies. Pharmaceutical companies, both local and international, are putting money into research focused on specific regional allergens, alongside public health initiatives aimed at improving treatment compliance and self-care.

According to the research report, ""India Allergy Treatment Market Overview, 2030,"" published by Bonafide Research, the India Allergy Treatment market is anticipated to grow at more than 9.06% CAGR from 2025 to 2030. India's market for allergy treatments is experiencing significant expansion, driven by rising rates of allergic conditions and a deliberate emphasis on enhancing healthcare systems while increasing patient access. The rapid growth of cities, heightened air pollution levels, and shifts in lifestyle are contributing to a rise in cases of asthma, allergic rhinitis, atopic dermatitis, and food allergies among various demographic segments. In response to this growing need, both governmental and private entities are investing in the enhancement of healthcare facilities, specialized clinics, and diagnostic services, particularly in major urban centers and tier-two cities. Initiatives from the government are focused on strengthening primary healthcare frameworks and incorporating allergy screenings into community health programs, which are leading to improved rates of early diagnosis. Moreover, the establishment of new medical colleges and training schemes is resulting in a greater number of allergists and respiratory health experts. Hospital pharmacies play a crucial role in providing prescription medications such as leukotriene receptor antagonists, corticosteroids, biologics, and allergen-specific immunotherapy, which are increasingly utilized for severe or chronic cases. Retail pharmacies provide widespread access to over-the-counter antihistamines, nasal sprays, and topical treatments suited for mild to moderate symptoms. Certified online pharmacies are addressing geographical challenges by delivering medications to semi-urban and rural residents, frequently in conjunction with telemedicine services. Pharmaceutical firms are broadening their treatment options through research and development tailored to local needs, including immunotherapy that focuses on common allergens like pollen, dust mites, and specific food allergens found in India.

India's market for allergy treatment by type is divided into allergies to food, allergies on the skin, and the rising awareness of eye allergies, which have often been overlooked. The significant increase in food allergies is especially noticeable in cities, where a greater intake of processed, packaged, and imported foods brings about new allergenic triggers, mainly affecting children and younger adults. Heightened awareness of diagnostics in city clinics has resulted in a rise in identified cases, with management methods including strict avoidance of certain foods, education for patients, and emergency medications like epinephrine auto-injectors. Skin allergies, which include atopic dermatitis, contact dermatitis, and chronic urticaria, are also increasing due to factors like environmental pollution, workplace exposures, and lifestyle changes. Treatments such as topical corticosteroids, calcineurin inhibitors, and emollient therapy are prevalent in this area, with specialized dermatology services in major cities promoting prompt intervention. Eye allergies—such as allergic conjunctivitis and vernal keratoconjunctivitis are still relatively under-diagnosed and often confused with infections, causing delays in treatment and ongoing discomfort for patients. Nonetheless, improved awareness among eye care professionals and the implementation of allergy screenings into eye health practices are starting to fill this gap. Treatments for eye allergies include antihistamine or mast-cell stabilizing eye drops, lubricants, and, in serious cases, topical corticosteroids under expert guidance. The distribution of these segments differs: hospital pharmacies primarily provide prescription medications for severe conditions, while retail shops offer over-the-counter antihistamines, topical treatments, and lubricants. Online pharmacies, aided by teleconsultations, are increasing access for both urban and semi-urban communities. Pharmaceutical companies are focusing on local allergen studies and patient education initiatives to aid early detection and treatment compliance. These areas highlight a market shifting from merely treating symptoms to a more focused and specific approach to care one that acknowledges the distinct patterns of food, skin, and eye allergies within India's changing healthcare environment.

India's market for allergy treatment by treatment type is divided into Anti-Allergy Drugs and Immunotherapy. A significant portion of this market includes over-the-counter antihistamines, intranasal steroid sprays, decongestants, and topical treatments for skin issues, all of which are widely accessible through retail and hospital pharmacies. These products are popular because they provide quick relief, are affordable, and have a solid track record in clinical use, making them the go-to choice for many patients. In specialist and advanced medical care settings, prescription-only drugs like leukotriene receptor antagonists and advanced biologics are becoming more common, especially for chronic or severe respiratory and skin allergies. The recognition and use of allergen-specific immunotherapy AIT which includes both subcutaneous and sublingual option are slowly growing, spurred by educational initiatives among allergists, respiratory experts, and dermatologists in major cities. AIT has the potential to change the disease progression by addressing underlying causes rather than merely relieving symptoms, making it an appealing long-term solution for appropriate patients. Nonetheless, its adoption is hindered by a shortage of specialists in smaller towns, the necessity for precise diagnostics, and the need for consistent treatment compliance. Local pharmaceutical firms, along with international companies, are putting resources into research on regional allergens like dust mites, pollen, and certain food allergens, customizing immunotherapy protocols to align with India’s specific health profiles. Medical associations, workshops, and ongoing educational programs are crucial in providing healthcare professionals with the latest information regarding the effectiveness, safety, and incorporation of immunotherapy into treatment plans. Although anti-allergy medications will likely continue to lead in the near future due to their ease of use and low cost, the increasing medical interest in immunotherapy suggests a gradual transition toward more preventive, disease-altering treatments, potentially transforming India's allergy treatment landscape into a more well-rounded and comprehensive care system in the next ten years.

The allergy treatments in India by distribution channel is divided into retail and hospital pharmacies, with online platforms quickly becoming a high-growth area, especially in urban locations. Retail pharmacies act as the most convenient care option for those with mild to moderate allergies, providing over-the-counter antihistamines, nasal sprays, eye drops, and topical treatments without needing a prescription. Their widespread presence, personalized advice from pharmacists, and quick availability of products help maintain their leading market position. In contrast, hospital pharmacies are the main providers of prescription therapies like leukotriene receptor antagonists, biologics, and allergen-specific immunotherapy. These pharmacies usually serve patients under the care of allergists, pulmonologists, or dermatologists, ensuring thorough oversight for complicated or chronic issues. The increase in severe allergies and more access to specialists in major cities has solidified their essential role. At the same time, online platforms are showing significant growth, spurred by the quick rise of smartphone usage, greater acceptance of digital payments, and growing consumer familiarity with online healthcare. Urban residents, who often have hectic lives and favor convenience, are leading this trend, particularly the younger, tech-savvy demographic that desires home delivery, competitive prices, and discreet purchasing options. The combination of online pharmacies with telemedicine and e-prescription services is improving access to both over-the-counter and prescription drugs, while subscription services and AI-based product suggestions are improving customer loyalty. The COVID-19 pandemic accelerated this transition, making virtual consultations and medicine orders more commonplace, as well as encouraging regulatory measures to enhance quality control for online sales. While retail and hospital pharmacies are likely to remain the primary options for the time being due to established systems and patient confidence, the ongoing growth of digital channels indicates that a mixed distribution model is forming one that incorporates physical access, clinical supervision, and technology-driven convenience to better cater to India’s increasingly diverse and urban allergy patient population.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Allergy Care Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Type
• Eye Allergy
• Skin Allergy
• Food Allergy
• Other Allergies

By Treatment Type
• Anti-Allergy Drugs
• Immunotherapy

By Distribution Channels
• Hospital Pharmacies
• Retail Pharmacies
• Online Retailers
• Others Show more